Prolonged response of relapsed high grade serous ovarian carcinoma to the oral angiokinase inhibitor nintedanib in a patient with a germline BRCA1 mutation.
about
Prolonged response of relapsed high grade serous ovarian carcinoma to the oral angiokinase inhibitor nintedanib in a patient with a germline BRCA1 mutation.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 17 October 2012
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Prolonged response of relapsed ...... ith a germline BRCA1 mutation.
@en
Prolonged response of relapsed ...... ith a germline BRCA1 mutation.
@nl
type
label
Prolonged response of relapsed ...... ith a germline BRCA1 mutation.
@en
Prolonged response of relapsed ...... ith a germline BRCA1 mutation.
@nl
prefLabel
Prolonged response of relapsed ...... ith a germline BRCA1 mutation.
@en
Prolonged response of relapsed ...... ith a germline BRCA1 mutation.
@nl
P2093
P2860
P1476
Prolonged response of relapsed ...... with a germline BRCA1 mutation
@en
P2093
Aileen Patterson
Ashley Shaw
Christine Parkinson
Han Hsi Wong
Jonathan A Ledermann
Mahmood Shafi
Michael Merger
P2860
P356
10.1016/J.GYNOR.2012.10.003
P577
2012-10-17T00:00:00Z